Fractional Excretion of Urate is Positively Associated with Type 2 Diabetes in HUA Patients: A Cross-Sectional Study
DOI: https://doi.org/10.2147/dmso.s454711
2024-04-13
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Bo Huang, &ast Xin Li, &ast Xinxin Zhang, Shiwei Li, Yue Liu, Mengjuan Zhang, Jingqiu Cui Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jingqiu Cui, Department of Endocrinology and Metabolism, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China, Tel +86 13920765604, Email Purpose: People with hyperuricemia (HUA) are often related to metabolic disorders such as diabetes, metabolic syndrome (MetS), and obesity. However, the correlation between excretion of uric acid and these diseases is unclear. Our study aimed to explore the relationship between uric acid excretion and type 2 diabetes (T2D). Methods: A total of 228 HUA patients from Tianjin Medical University General Hospital from 2022 to 2023 were included in this study. We collected demographic, biochemical, and anthropometric data on each subject. Urine uric acid excretion (UUAE) was calculated enzymatically from a single urine collection that lasted 24 hours. And fractional excretion of uric acid (FEUA) was calculated from serum uric acid and creatinine and uric acid and creatinine. Binary logistic regression modeling assessed the association between uric acid excretion and T2D. Results: Of the 228 subjects, 13.4% had T2D and 48.7% had obesity. The obesity group had a lower FEUA (p< 0.05) and a higher UUAE compared to the control group (p< 0.05). And FEUA had a stronger correlation with the risk of T2D (p< 0.001). Also, there was a negative association between BMI and FEUA and a positive link between BMI and UUAE in the outpatients. Conclusion: Increased FEUA levels were significantly associated with T2D in HUA patients. Therefore, routine calculating of FEUA is essential for proper diagnosis and appropriate treatment T2D of in HUA patients. Keywords: urine uric acid excretion, hyperuricemia, obesity, Type 2 diabetes, fractional excretion of urate Graphical HUA constitutes a metabolic disorder primarily attributed to disturbances in purine metabolism, which the prevalence of in Chinese adults was 14.0%. 1 In humans, purines are ultimately metabolized into uric acid, which can further convert uric acid into allantoin by the enzyme uricase, readily excretable through urine. However, the enzyme uricase is absent in the human body. 2 The kidneys play a pivotal role in regulating amounts of uric acid in the circulation. Nearly two-thirds of uric acid goes away via the kidneys, while the remaining one-third leaves the body through the intestinal tract uricolysis. 3 Renal capacity, though, is finite. HUA may arise from a disturbance in the balance between the production and excretion of uric acid. All the time, research is being done on the link between serum uric acid (SUA) and several metabolic disorders, including diabetes, 4,5 hypertension, 6,7 obesity, 8 metabolic syndrome, 9 dyslipidemia, 10 kidney dysfunction, 11 liver dysfunction, 12 and cardiovascular disease. 13 A prospective study demonstrated that higher SUA levels increase the risk of developing diabetes. 14 Recently lower cut-offs for HUA have been defined since they are more strongly associated with CV diseases. HUA was diagnosed both with the classic cut-off of 6.0 mg/dl for females and 7.0 mg/dl for males, but also with the newly identified one in the URRAH (Uric Acid Right for Heart Health) study that is 5.1 mg/dl for females and 5.6 mg/dl for males. 15 The threshold of 5.6 mg/dl previously proposed by the URRAH Study Group, is predictive of an increased risk of total and CV mortality in people with diabetes. 16 The newly reported URRAH cutoff values for HUA better relate to atherogenic lipoprotein (LDL and non-HDL) when compared to the classic one. 17 Also, treating hyperinsulinemia and diabetes-related insulin resistance with troglitazone or a low-energy diet in overweight hypertensive patients lowers serum UA levels. 18 Additionally, several publications have shown the independent impact of SUA on the onset of MetS and hypertension in Chinese hospitalized type 2 diabetic patients. 19 A population-based longitudinal epidemiological investigation found a link between raised concentrations of SUA and an elevated risk of obesity. 20 In healthy patients, a prior Chinese study likewise revealed a favorable correlation between BMI and SUA. 21 Overall, these investigations repeatedly show that higher SUA levels are strongly associated with metabolic problems in individuals with -Abstract Truncated-
endocrinology & metabolism